These results demonstrate that CARD11 is a bona fide oncogene in DLBCL, providing a genetic rationale for the development of pharmacological inhibitors of the CARD11 pathway for DLBCL therapy.
这些结果表明在DLBCL中，CARD11是真正的癌基因，对DLBCL治疗中用药物抑制CARD11通路提供了遗传学理论。
It is the first to demonstrate that combining human monoclonal antibodies with cytokines can be an effective cancer therapy.
它是首次阐明了细胞因子联合人单克隆抗体可以有效地治疗癌症。
It is the first to demonstrate that combining human monoclonal antibodies with cytokines can be an effective cancer therapy.
它是首次阐明了细胞因子联合人单克隆抗体可以有效地治疗癌症。
应用推荐